Article Correctness Is Author's Responsibility: Prostate cancer bone metastases thwart immunotherapy by producing TGF-β

Prostate cancer that spreads to the bone triggers the destruction of bone tissue that thwarts the effectiveness of immune checkpoint inhibitors. Research points to anti-CTLA-4 and anti-TGF-B combination to protect T cells.